No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Liability for investment contracts and universal life insurance products No authoritative reference available. Total of fixed maturity securities of consolidated variable interest entities where we are the primary beneficiary. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. All amounts related to share-based compensation plans. Includes the value of stock issued during the period as a result of any share-based compensation plans and the amount of share-based compensation recognized during the period as expense in the income statement. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Tax effect of the adoption of new guidance for other-than-temporary impairments of debt securities No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Disclosure of certain attributes of our investment portfolio. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Adoption of new guidance for other-than-temporary impairments of debt securities No authoritative reference available. No authoritative reference available. No authoritative reference available. Total other-than-temporary impairment losses consist of credit losses recognized through net income (loss) and non-credit losses recognized through accumulated other comprehensive income (loss). No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Purchases of investments during the period primarily related to actively managed fixed maturities. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Change in borrowings during the period related to: (i) amounts borrowed by variable interest entities of which we are the primary beneficiary; and (ii) other borrowings by a wholly owned subsidiary primarily from the Federal Home Loan Bank of Indianapolis. No authoritative reference available. No authoritative reference available. No authoritative reference available. Payments made during the period related to debt modification and extinguishment of debt. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Amounts borrowed by a wholly owned subsidiary primarily from the Federal Home Loan Bank of Indianapolis; the proceeds of which were used to purchase fixed maturity securities. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Total of cash and cash equivalents of consolidated variable interest entities where we are the primary beneficiary. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Net investment income on general account invested assets excludes income (loss) related to: (i) the change in the fair value of options purchased in an effort to hedge certain benefits accruing to the policyholders of our equity-indexed products; (ii) trading account securities; (iii) change in value of embedded derivatives related to modified coinsurance agreements; and (iv) Company-only life insurance which was purchased as an investment vehicle to fund a deferred compensation plan. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Represents realized investment gains (losses) resulting from the sale or disposition of investments. No authoritative reference available. Change in cash and cash equivalents during the period held by variable interest entities of which we are the primary beneficiary. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Amounts paid to policyholders during the period pursuant to the terms of the insurance contracts. No authoritative reference available. No authoritative reference available. No authoritative reference available. Such amount represents net investment income (loss) related to: (i) the change in the fair value of options purchased in an effort to hedge certain potential benefits accruing to the policyholders of our equity-indexed products; (ii) trading account securities; (iii) change in value of embedded derivatives related to modified coinsurance agreements; and (iv) Company-only life insurance which was purchased as an investment vehicle to fund the deferred compensation plan for certain agents. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. For an unclassified balance sheet, this item represents the cost of equity securities categorized neither as held-to-maturity nor trading. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Sales of investments during the period primarily resulting from sales of actively managed fixed maturities. No authoritative reference available. No authoritative reference available. No authoritative reference available. Appreciation or loss in value of the total of unsold securities (on which a noncredit impairment loss has been previously recognized) during the period being reported on, net of tax No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Payments made during the reporting period related to costs associated with acquiring new insurance customers. No authoritative reference available. Tax effect on the appreciation or loss in value of the total of unsold securities (on which a noncredit impairment loss has been previously recognized) during the period being reported on No authoritative reference available. No authoritative reference available. No authoritative reference available. Maturities and redemptions of investments during the period primarily resulting from actively managed fixed maturities. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Net amounts received or paid for trading securities during the period. No authoritative reference available. The borrowings of the variable interest entities that are to be repaid from available cash flows from the assets of the variable interest entities. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Represents other-than-temporary impairments recognized through net income (loss). No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Represents the portion of an other-than-temporary impairment (recognized in accumulated other comprehensive income (loss))that is the difference between the security's estimated fair value and our best estimate of future cash flows discounted at the effective interest rate prior to impairment. No authoritative reference available. No authoritative reference available. No authoritative reference available.